In Vitro–In Vivo Correlation (Ivivc): A Biopharmaceutical Tool To Shorten Development Duration

Authors

  • Taru Dube Department of Pharmaceutics, STES’s Sinhgad College of Pharmacy, Vadgaon (Bk.) Pune, India.
  • Piyush Upadhyay Department of Pharmacology, STES’s Sinhgad Institute of Pharmacy, Narhe, Pune, India.

Keywords:

IVIVC, GastroPlus, TIM1, DDASS, Wagner-nelson method, Loo-Reigelman method

Abstract

United States Food and Drug Administration (FDA) have given guidelines for both immediate and modified release dosage so as to minimize bioavailability studies during formulation design and optimization. An in vitro–in vivo correlation (IVIVC) may be defined as a predictive mathematical model describing the relationship between an in vitro property and a relevant in vivo response. When a meaningful IVIVC has been established, it can be used as a surrogate for bioequivalence potentially minimizing the number of bioequivalence studies to be performed during drug product development. An IVIVC can be used to request biowaivers from regulatory agencies for certain formulation or production changes within the lifecycle of a product. This reduces the need for expensive bioequivalence testing in humans. This review article presents a comprehensive overview of systematic procedure for establishing and validating an in vitro in vivo correlation level A, B and C. It encompasses all mathematical concepts of IVIVC development such as GastroPlus™, TIM1, Drug Dissolution/Absorption Simulating System (DDASS) and other methods.

Downloads

Download data is not yet available.

Published

2013-07-01

How to Cite

Dube, T., & Upadhyay, P. (2013). In Vitro–In Vivo Correlation (Ivivc): A Biopharmaceutical Tool To Shorten Development Duration. Asian Journal of Pharmaceutical Research and Development, 1(4), 67–72. Retrieved from https://ajprd.com/index.php/journal/article/view/78

Issue

Volume 1st issue 4th July-Aug 2013

Section

Review Articles

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).